Word

IMMUNICH

Status

Dead

Status Code

710

Status Date

Friday, September 3, 2010

Serial Number

76230157

Registration Number

2807717

Registration Date

Tuesday, January 27, 2004

Mark Type

1000

Filing Date

Friday, March 23, 2001

Published for Opposition

Tuesday, November 4, 2003

Cancellation Date

Friday, September 3, 2010

Trademark Owner History

CONNEX Gesellschaft zur Optimierung vonForschung und Entwicklung mbH - Original Registrant

Classifications

1 chemical products for industrial and scientific research purposes, namely, reagent test strips, test reagents, and scientific research aerosols, for performing analytical reactions for the purpose of environmental analysis, toxicological analysis, foodstuff analysis, pharmacological analysis, for use in the research and development of medical and veterinary medicine; test reagents for analytical studies of human and animal samples, namely, blood, urine, stool and other body fluids and aerosols, for the analysis of agricultural products, for environmental analysis, toxicological analysis, foodstuff analysis, pharmacological analysis; diagnostic reagents, reagent mixtures, substrates, buffer substances and solutions for scientific research, namely, buffer solutions, control solutions, substrate solutions, and stopping reagents appropriate for such analyses; chemical, biochemical and biological products for performing analytical studies in scientific research, namely diagnostic reagents for the diagnosis of excreta; cellular assays for scientific research use; scientific research test kits comprised primarily of reaction vessels namely, coated reaction microtitration plates and reaction tubes, reagents, reagent mixtures, substrates, and buffer substances

5 Chemical, biochemical, and biological products for performing analytical studies in clinical settings, namely, diagnostic reagents for diagnosis of excreta; pharmaceutical and veterinary products and preparations for health care, namely, diagnostic agents, reagents and reagent mixtures for use in the clinical medical and veterinary fields; diagnostic agents, reagents, and reagent mixtures for the clinical diagnosis of diseases, namely, infectious diseases, system diseases, and auto-aggressive diseases in humans and animals, namely, for examining bodily fluids and respiratory condensate; therapeutic agents containing proteins; polypeptide or peptides, monoclonal or polygonal antibodies for clinical medical use; expression systems, namely, systems consisting of procaryotic or enearyotic expression cells and expression vectors for clinical use; cellular assays for clinical medical use; clinical medical test kits comprised primarily of reaction vessels, namely coated reaction microtitration plates and reaction tubes, reagents, reagent mixtures, substrates, buffer substances, and solutions for performing analyses, namely, buffer solutions, control solutions, substrate solutions, and stopping reagents

10 devices and test components for analytical studies of human and animal samples of blood, urine, stool and other body fluids; receptacles and devices for collecting human bodily fluid samples, namely, blood drawing apparatus and urine flasks; apparatus for the production of antibodies; apparatus for receiving expression systems; apparatus for collecting human bodily fluid samples for medical, scientific and veterinary purposes

42 scientific and industrial research; medical laboratory services, development of new technology for others in the field of cell culture, monoclonal antibodies, peptides, polypeptides and proteins, genetic expression systems, cellular assays, and production of chemical compounds; product research and development performed under contact for the benefit of others; development and implementation of diagnostic and analytical procedures for others in the field of environmental analysis, toxicological analysis, foodstuff analysis, pharmacological analysis, diagnosis of infectious diseases, system diseases and auto-aggressive diseases in humans and animals; development of therapeutic compositions for others in the field of curing diseases of humans and animals, namely compositions on an immunological basis for curing diseases; research and development for others of biological systems, namely, genetic expression systems, cellular assays and animal cellular models

Trademark Events

Sep 3, 2010

Cancelled Sec. 8 (6-Yr)

Sep 16, 2006

Review Of Correspondence Complete

Aug 12, 2006

Review Of Correspondence Complete

Oct 7, 2004

Paper Received

Jan 27, 2004

Registered-Principal Register

Nov 4, 2003

Published For Opposition

Oct 15, 2003

Notice Of Publication

Aug 14, 2003

Approved For Pub - Principal Register

Jul 14, 2003

Paper Received

Jul 14, 2003

Correspondence Received In Law Office

Jul 23, 2003

Case File In Ticrs

Apr 30, 2003

Final Refusal Mailed

Mar 28, 2003

Sec. 1(B) Claim Deleted

Mar 28, 2003

Correspondence Received In Law Office

Mar 28, 2003

Paper Received

Jan 3, 2003

Assigned To Examiner

Sep 26, 2002

Inquiry As To Suspension Mailed

Mar 12, 2002

Letter Of Suspension Mailed

Jan 11, 2002

Correspondence Received In Law Office

Jul 17, 2001

Non-Final Action Mailed

Jul 11, 2001

Assigned To Examiner